AI Analysis of PET/CT Images can Predict Side Effects of Immunotherapy in Lung Cancer

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious side effect of immunotherapy in lung cancer.

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious side effect called interstitial lung disease. Interstitial lung disease is characterized by scarring (fibrosis) of the lungs and may be life-threatening owing to respiratory failure. Unfortunately, it is difficult to predict the occurrence of interstitial lung disease induced by immunotherapy. Accordingly, effective methods for predicting the risk of developing interstitial lung disease after immunotherapy are required.

This retrospective study investigated 165 patients with primary lung cancer who received immunotherapy at Niigata University Medical and Dental Hospital. As it is suggested that interstitial lung disease arises when inflammatory cells activated through immunotherapy damage healthy lung as well as cancer cells, the researchers hypothesized that patients with severe inflammation in healthy lungs prior to immunotherapy are more likely to develop interstitial lung disease after the treatment. Dr. Watanabe and his teams focused on PET/CT scan, a nuclear imaging test that is able to detect inflammation in the whole body. The researchers quantified the degree of inflammation in noncancerous lungs, namely lung regions without cancer, using AI analysis of PET/CT images. The study demonstrated that the risk of developing interstitial lung disease after immunotherapy is approximately 6.5 times higher in patients with high inflammation in the noncancerous lung than in those with low inflammation.

Dr. Yamazaki says "PET/CT is generally performed to detect cancer metastasis, but it would potentially be useful for estimating the risks of side effects associated with cancer treatment. The results of our study may not only help to predict the occurrence of interstitial lung disease after immunotherapy, but also to elucidate the mechanism of this serious side effect. We should conduct a multicenter prospective study for further investigation."

Yamazaki M, Watanabe S, Tominaga M, Yagi T, Goto Y, Yanagimura N, Arita M, Ohtsubo A, Tanaka T, Nozaki K, Saida Y, Kondo R, Kikuchi T, Ishikawa H.
18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors.
Acad Radiol. 2024 Sep 2:S1076-6332(24)00606-8. doi: 10.1016/j.acra.2024.08.043

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...